1	Ras	Ras	_	_	_	_	_	_	_
2	oncogene	oncogene	_	_	_	_	_	_	_
3	transformation	transformation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	lymphoblasts	lymphoblast	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	lymphocyte	lymphocyte	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	block	block	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	differentiation	differentiation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	p21ras	p21ras	_	_	_	_	_	_	_
3	small	small	_	_	_	_	_	_	_
4	GTP	GTP	_	_	_	_	_	_	_
5	binding	binding	_	_	_	_	_	_	_
6	proteins	protein	_	_	_	_	_	_	_
7	participate	participate	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	signal	signal	_	_	_	_	_	_	_
10	transduction	transduction	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	cell	cell	_	_	_	_	_	_	_
13	surface	surface	_	_	_	_	_	_	_
14	receptors	receptor	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	affect	affect	_	_	_	_	_	_	_
17	neoplastic	neoplastic	_	_	_	_	_	_	_
18	transformation	transformation	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	development	development	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	many	many	_	_	_	_	_	_	_
23	different	different	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	types	type	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	present	present	_	_	_	_	_	_	_
4	study	study	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	examined	examine	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	relationship	relationship	_	_	_	_	_	_	_
10	between	between	_	_	_	_	_	_	_
11	ras	ras	_	_	_	_	_	_	_
12	transformation	transformation	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	differentiation	differentiation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	human	human	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	T24	T24	_	_	_	_	_	_	_
10	Ha-ras	Ha-ras	_	_	_	_	_	_	_
11	oncogene	oncogene	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	EBV-immortalized	ebv-immortalized	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	lymphoblasts	lymphoblast	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	associated	associate	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	induction	induction	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	interleukin	interleukin	_	_	_	_	_	_	_
24	2	2	_	_	_	_	_	_	_
25	receptor	receptor	_	_	_	_	_	_	_
26	alpha	alpha	_	_	_	_	_	_	_
27	subunit	subunit	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	an	an	_	_	_	_	_	_	_
31	impaired	impaired	_	_	_	_	_	_	_
32	immunoglobulin	immunoglobulin	_	_	_	_	_	_	_
33	gene	gene	_	_	_	_	_	_	_
34	expression	expression	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	altered	altered	_	_	_	_	_	_	_
37	adhesion	adhesion	_	_	_	_	_	_	_
38	properties	property	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	increased	increase	_	_	_	_	_	_	_
41	survival	survival	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	serum-free	serum-free	_	_	_	_	_	_	_
44	medium	medium	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	induction	induction	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	IL-2	il-2	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	alpha	alpha	_	_	_	_	_	_	_
8	subunit	subunit	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	hallmark	hallmark	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	lymphocyte	lymphocyte	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	we	we	_	_	_	_	_	_	_
17	suggest	suggest	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	p21ras	p21ras	_	_	_	_	_	_	_
20	naturally	naturally	_	_	_	_	_	_	_
21	triggers	trigger	_	_	_	_	_	_	_
22	B	B	_	_	_	_	_	_	_
23	cell	cell	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	ras-transformed	ras-transformed	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	displayed	display	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	fully	fully	_	_	_	_	_	_	_
7	functional	functional	_	_	_	_	_	_	_
8	IL-2r	IL-2r	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	assessed	assess	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	c-fos	c-fos	_	_	_	_	_	_	_
14	induction	induction	_	_	_	_	_	_	_
15	following	follow	_	_	_	_	_	_	_
16	treatment	treatment	_	_	_	_	_	_	_
17	with	with	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	;	;	_	_	_	_	_	_	_
20	nevertheless	nevertheless	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	they	they	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	growth	growth	_	_	_	_	_	_	_
26	stimulated	stimulate	_	_	_	_	_	_	_
27	by	by	_	_	_	_	_	_	_
28	this	this	_	_	_	_	_	_	_
29	lymphokine	lymphokine	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	decreased	decrease	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	immunoglobulin	immunoglobulin	_	_	_	_	_	_	_
6	genes	gene	_	_	_	_	_	_	_
7	indicates	indicate	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	ras	ras	_	_	_	_	_	_	_
11	oncogene	oncogene	_	_	_	_	_	_	_
12	blocks	block	_	_	_	_	_	_	_
13	terminal	terminal	_	_	_	_	_	_	_
14	differentiation	differentiation	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	plasma	plasma	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	possibly	possibly	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	inhibiting	inhibit	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	activity	activity	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	lymphocyte-specific	lymphocyte-specific	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	factors	factor	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Somewhat	somewhat	_	_	_	_	_	_	_
2	unexpectedly	unexpectedly	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	p21ras	p21ras	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	did	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	cause	cause	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	DNA	dna	_	_	_	_	_	_	_
14	binding	binding	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	factors	factor	_	_	_	_	_	_	_
18	PEA1	pea1	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	AP1	AP1	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	PEA3	PEA3	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	Oct-2	Oct-2	_	_	_	_	_	_	_
26	or	or	_	_	_	_	_	_	_
27	NF-kB	NF-kB	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

